OAS1 and breast cancer: As for examples with the enriched BPs, the cell growth inhibition of MCF-7 (the BC cell line) significantly increases after treatment of BC with XN by influencing the type I interferon signaling pathway [46] that is associated with three KGs (OAS1, OAS3 and IRF9).